Achieve Life Sciences
ACHV
ACHV
70 hedge funds and large institutions have $57.5M invested in Achieve Life Sciences in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 64 → 70 (+6)
1.79% less ownership
Funds ownership: 49.3% → 47.52% (-1.8%)
29% less capital invested
Capital invested by funds: $81.2M → $57.5M (-$23.7M)
Holders
70
Holding in Top 10
2
Calls
$2.43M
Puts
$2K
Top Buyers
| 1 | +$176K | |
| 2 | +$156K | |
| 3 | +$154K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$127K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$112K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$731K | |
| 3 | -$671K | |
| 4 |
Goldman Sachs
New York
|
-$295K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$176K |